My Quote Request
No products added yet
6505-01-231-7283
20 Products
RETIN-A GEL
TRETINOIN GEL,USP
NSN, MFG P/N
6505012317283
NSN
6505-01-231-7283
MFG
ORTHO DIAGNOSTIC SYSTEMS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.010 PERCENTAGE, W/W RETINOIC ACID ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRETINOIN GEL USP 0.01% 45GM TUBE 24S
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
INDOCIN
INDOMETHACIN SUPPOSITORIES,USP
NSN, MFG P/N
6505012317284
NSN
6505-01-231-7284
INDOCIN
INDOMETHACIN SUPPOSITORIES,USP
NSN, MFG P/N
6505012317284
NSN
6505-01-231-7284
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INDOMETHACIN SUPPOSITORIES USP 50MG ADULT RECTAL I.S. 30S
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: 50 MG
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 30
Related Searches:
NDC00006-0150-30
INDOMETHACIN SUPPOSITORIES,USP
NSN, MFG P/N
6505012317284
NSN
6505-01-231-7284
NDC00006-0150-30
INDOMETHACIN SUPPOSITORIES,USP
NSN, MFG P/N
6505012317284
NSN
6505-01-231-7284
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INDOMETHACIN SUPPOSITORIES USP 50MG ADULT RECTAL I.S. 30S
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: 50 MG
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 30
Related Searches:
84-50
SODIUM BICARBONATE INJECTION,USP
NSN, MFG P/N
6505012317302
NSN
6505-01-231-7302
84-50
SODIUM BICARBONATE INJECTION,USP
NSN, MFG P/N
6505012317302
NSN
6505-01-231-7302
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.500 PERCENTAGE, W/V SODIUM BICARBONATE ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LYPHOMED INC
III THERAPEUTIC EQUIVALENT: LYPHOMED,INC
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00469-8400-60
SODIUM BICARBONATE INJECTION,USP
NSN, MFG P/N
6505012317302
NSN
6505-01-231-7302
NDC00469-8400-60
SODIUM BICARBONATE INJECTION,USP
NSN, MFG P/N
6505012317302
NSN
6505-01-231-7302
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.500 PERCENTAGE, W/V SODIUM BICARBONATE ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LYPHOMED INC
III THERAPEUTIC EQUIVALENT: LYPHOMED,INC
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
97-B1
CALCIUM GLUCONATE INJECTION,USP
NSN, MFG P/N
6505012317303
NSN
6505-01-231-7303
97-B1
CALCIUM GLUCONATE INJECTION,USP
NSN, MFG P/N
6505012317303
NSN
6505-01-231-7303
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 94.000 MILLIGRAMS CALCIUM GLUCONATE PER MILLILITER AND MILLIGRAMS CALCIUM SACCHARATE,TETRAHYDRATE PER MILLILITER 5.000
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III THERAPEUTIC EQUIVALENT: NOT LISTED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 40
Related Searches:
NDC00469-9701-00
CALCIUM GLUCONATE INJECTION,USP
NSN, MFG P/N
6505012317303
NSN
6505-01-231-7303
NDC00469-9701-00
CALCIUM GLUCONATE INJECTION,USP
NSN, MFG P/N
6505012317303
NSN
6505-01-231-7303
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 94.000 MILLIGRAMS CALCIUM GLUCONATE PER MILLILITER AND MILLIGRAMS CALCIUM SACCHARATE,TETRAHYDRATE PER MILLILITER 5.000
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III THERAPEUTIC EQUIVALENT: NOT LISTED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 40
Related Searches:
NDC47679-0412-52
DOCUSATE SODIUM SOLUTION,MODIFIED
NSN, MFG P/N
6505012319093
NSN
6505-01-231-9093
NDC47679-0412-52
DOCUSATE SODIUM SOLUTION,MODIFIED
NSN, MFG P/N
6505012319093
NSN
6505-01-231-9093
MFG
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: DOCUSATE SODIUM 100 MG. ACTIVE INGREDIENT
III THERAPEUTIC EQUIVALENT: NOT RATED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
FORTAZ
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012319931
NSN
6505-01-231-9931
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 500GM VIAL 25S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO INC
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00173-0377-31
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012319931
NSN
6505-01-231-9931
NDC00173-0377-31
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505012319931
NSN
6505-01-231-9931
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 500GM VIAL 25S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO INC
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC17478-0102-20
TROPICAMIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012321769
NSN
6505-01-232-1769
NDC17478-0102-20
TROPICAMIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012321769
NSN
6505-01-232-1769
MFG
AKORN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V TROPICAMIDE ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: NOT RATED
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: PRESERVATIVE ADDED
Related Searches:
TROPICACYL
TROPICAMIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012321769
NSN
6505-01-232-1769
TROPICACYL
TROPICAMIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505012321769
NSN
6505-01-232-1769
MFG
AKORN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V TROPICAMIDE ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: NOT RATED
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: PRESERVATIVE ADDED
Related Searches:
99-1131
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505012321987
NSN
6505-01-232-1987
99-1131
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505012321987
NSN
6505-01-232-1987
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS METHYLPREDNISOLONE EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SOD SUCCINATE F/INJ USP 2 GRAMS IN 50ML VIAL
III THERAPEUTIC EQUIVALENT: RATED AP
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 GM. POWDER IN 50 ML. VIAL AND 30 ML. DILUENT IN SEPARATE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 2
Related Searches:
NDC00009-0796-01
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505012321987
NSN
6505-01-232-1987
NDC00009-0796-01
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505012321987
NSN
6505-01-232-1987
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS METHYLPREDNISOLONE EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SOD SUCCINATE F/INJ USP 2 GRAMS IN 50ML VIAL
III THERAPEUTIC EQUIVALENT: RATED AP
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 GM. POWDER IN 50 ML. VIAL AND 30 ML. DILUENT IN SEPARATE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 2
Related Searches:
SOLU-MEDROL
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505012321987
NSN
6505-01-232-1987
SOLU-MEDROL
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505012321987
NSN
6505-01-232-1987
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS METHYLPREDNISOLONE EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SOD SUCCINATE F/INJ USP 2 GRAMS IN 50ML VIAL
III THERAPEUTIC EQUIVALENT: RATED AP
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 GM. POWDER IN 50 ML. VIAL AND 30 ML. DILUENT IN SEPARATE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 2
Related Searches:
ANGIOVIST 282
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012321988
NSN
6505-01-232-1988
ANGIOVIST 282
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012321988
NSN
6505-01-232-1988
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: RATED AP
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
NDC50419-0192-10
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012321988
NSN
6505-01-232-1988
NDC50419-0192-10
DIATRIZOATE MEGLUMINE INJECTION,USP
NSN, MFG P/N
6505012321988
NSN
6505-01-232-1988
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: RATED AP
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
NDC68516-3200-02
FACTOR IX COMPLEX,USP
NSN, MFG P/N
6505012322025
NSN
6505-01-232-2025
NDC68516-3200-02
FACTOR IX COMPLEX,USP
NSN, MFG P/N
6505012322025
NSN
6505-01-232-2025
MFG
GRIFOLS BIOLOGICALS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FACTOR IX COMPLEX USP FREEZE DRIED POWDER 500 UNITS PER VIAL
III SUPPLEMENTARY FEATURES: NOTE: G,F
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH PACKAGE CONTAINS:1 VIAL CONTAINING 500 UNITS (HEAT TREATED) PLUS OR MINUS 20 PCT FACTOR IX COMPLEX;STERILE FILTER NEEDLE;1 VIAL CONTAINING SUFFICIENT STERILE WATER FOR INJECTION,USP TO RECONSTITUTE THE PRODUCT
Related Searches:
PROFILNINE
FACTOR IX COMPLEX,USP
NSN, MFG P/N
6505012322025
NSN
6505-01-232-2025
MFG
GRIFOLS BIOLOGICALS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FACTOR IX COMPLEX USP FREEZE DRIED POWDER 500 UNITS PER VIAL
III SUPPLEMENTARY FEATURES: NOTE: G,F
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH PACKAGE CONTAINS:1 VIAL CONTAINING 500 UNITS (HEAT TREATED) PLUS OR MINUS 20 PCT FACTOR IX COMPLEX;STERILE FILTER NEEDLE;1 VIAL CONTAINING SUFFICIENT STERILE WATER FOR INJECTION,USP TO RECONSTITUTE THE PRODUCT
Related Searches:
ARM-A-VIAL
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012323114
NSN
6505-01-232-3114
ARM-A-VIAL
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012323114
NSN
6505-01-232-3114
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PARABEN AND PRESERVATIVE-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 100
